3D Printing Emerging Technologies and Functionality of Polymeric Excipients in Drug Product Development /
This book is an educational text and guide for the use and properties of key polymeric excipients in the area of 3D printing in drug development. It is written by both industry experts and academic researchers. The particular focus is on hot melt extrusion and the extruded filaments suitable for opt...
Պահպանված է:
| Համատեղ հեղինակ: | |
|---|---|
| Այլ հեղինակներ: | , |
| Ձևաչափ: | Էլեկտրոնային էլ․ գիրք |
| Լեզու: | անգլերեն |
| Հրապարակվել է: |
Cham :
Springer International Publishing : Imprint: Springer,
2024.
|
| Հրատարակություն: | 1st ed. 2024. |
| Շարք: | AAPS Advances in the Pharmaceutical Sciences Series,
44 |
| Խորագրեր: | |
| Առցանց հասանելիություն: | https://doi.org/10.1007/978-3-031-46015-9 |
| Ցուցիչներ: |
Ավելացրեք ցուցիչ
Չկան պիտակներ, Եղեք առաջինը, ով նշում է այս գրառումը!
|
MARC
| LEADER | 00000nam a22000005i 4500 | ||
|---|---|---|---|
| 001 | 978-3-031-46015-9 | ||
| 003 | DE-He213 | ||
| 005 | 20251113212444.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 231201s2024 sz | s |||| 0|eng d | ||
| 020 | |a 9783031460159 |9 978-3-031-46015-9 | ||
| 024 | 7 | |a 10.1007/978-3-031-46015-9 |2 doi | |
| 050 | 4 | |a RS400-431 | |
| 072 | 7 | |a PSB |2 bicssc | |
| 072 | 7 | |a SCI013040 |2 bisacsh | |
| 072 | 7 | |a PNB |2 thema | |
| 082 | 0 | 4 | |a 615.19 |2 23 |
| 245 | 1 | 0 | |a 3D Printing |h [electronic resource] : |b Emerging Technologies and Functionality of Polymeric Excipients in Drug Product Development / |c edited by Michael A. Repka, Nigel Langley. |
| 250 | |a 1st ed. 2024. | ||
| 264 | 1 | |a Cham : |b Springer International Publishing : |b Imprint: Springer, |c 2024. | |
| 300 | |a XI, 288 p. 100 illus., 94 illus. in color. |b online resource. | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 341 | 0 | |b Table of contents navigation |2 onix | |
| 341 | 0 | |b Single logical reading order |2 onix | |
| 341 | 0 | |b Short alternative textual descriptions |2 onix | |
| 341 | 0 | |b Use of color is not sole means of conveying information |2 onix | |
| 341 | 0 | |b Use of high contrast between text and background color |2 onix | |
| 341 | 0 | |b Next / Previous structural navigation |2 onix | |
| 341 | 0 | |b All non-decorative content supports reading without sight |2 onix | |
| 347 | |a text file |b PDF |2 rda | ||
| 490 | 1 | |a AAPS Advances in the Pharmaceutical Sciences Series, |x 2210-738X ; |v 44 | |
| 505 | 0 | |a Overview of Pharmaceutical 3D Printing Technologies -- Clinical Benefit of 3D Printed Products -- Characterization or Quality Control of 3D Printed Products -- Polymers for HME based 3D Printing -- Cellulosic Polymers -- API and Polymer Selection Formulation and Process Variables -- Fused Deposition Modeling 3D Printing.-Semi-solid Extrusion Printing and 3D -- Future Trends Including Novel Polymeric Excipients Designed for Purpose Bioprinting. | |
| 520 | |a This book is an educational text and guide for the use and properties of key polymeric excipients in the area of 3D printing in drug development. It is written by both industry experts and academic researchers. The particular focus is on hot melt extrusion and the extruded filaments suitable for optimizing the 3D printing in drug development. 3D Printing Polymeric Excipients, Technology, and Drug Formulation Development covers regulatory aspects as well as the manufacturing aspects. | ||
| 532 | 8 | |a Accessibility summary: This PDF does not fully comply with PDF/UA standards, but does feature limited screen reader support, described non-text content (images, graphs), bookmarks for easy navigation and searchable, selectable text. Users of assistive technologies may experience difficulty navigating or interpreting content in this document. We recognize the importance of accessibility, and we welcome queries about accessibility for any of our products. If you have a question or an access need, please get in touch with us at accessibilitysupport@springernature.com. | |
| 532 | 8 | |a No reading system accessibility options actively disabled | |
| 532 | 8 | |a Publisher contact for further accessibility information: accessibilitysupport@springernature.com | |
| 650 | 0 | |a Pharmaceutical chemistry. | |
| 650 | 0 | |a Pharmacology. | |
| 650 | 0 | |a Biotechnology. | |
| 650 | 0 | |a Biology |x Technique. | |
| 650 | 1 | 4 | |a Pharmaceutics. |
| 650 | 2 | 4 | |a Pharmacology. |
| 650 | 2 | 4 | |a Biotechnology. |
| 650 | 2 | 4 | |a Biological Techniques. |
| 700 | 1 | |a Repka, Michael A. |e editor. |0 (orcid)0000-0003-2049-4696 |1 https://orcid.org/0000-0003-2049-4696 |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 700 | 1 | |a Langley, Nigel. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 710 | 2 | |a SpringerLink (Online service) | |
| 773 | 0 | |t Springer Nature eBook | |
| 776 | 0 | 8 | |i Printed edition: |z 9783031460142 |
| 776 | 0 | 8 | |i Printed edition: |z 9783031460166 |
| 776 | 0 | 8 | |i Printed edition: |z 9783031460173 |
| 830 | 0 | |a AAPS Advances in the Pharmaceutical Sciences Series, |x 2210-738X ; |v 44 | |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-3-031-46015-9 |
| 912 | |a ZDB-2-SBL | ||
| 912 | |a ZDB-2-SXB | ||
| 950 | |a Biomedical and Life Sciences (SpringerNature-11642) | ||
| 950 | |a Biomedical and Life Sciences (R0) (SpringerNature-43708) | ||